Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01548560 · ClinicalTrials.gov registry record · Phase 1
Assessing the Safety of Dapivirine Gel and Film Formulations
A Phase 1 study, sponsored by International Partnership for Microbicides.
- Completed
- Registry status
- Phase 1
- Development phase
- 60
- Enrollment target
NCT01548560 is a Phase 1 study that has completed, run by International Partnership for Microbicides. The registered enrollment target is 60 participants.
The verdict
NCT01548560, a Phase 1 study, has completed, sponsored by International Partnership for Microbicides.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 60 participants
- Enrollment target
Study Summary
This is a study to determine the safety of dapivirine gel and dapvirine film for healthy, HIV-uninfected women aged 18-45 years using the product for 7 daily doses.
Interventions
- DRUG Dapivirine Vaginal Film
- DRUG Dapivirine Vaginal Gel
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2012-08 |
| Est. Completion | 2014-02 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01548560
The ClinicalTrials.gov registry entry for NCT01548560 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is International Partnership for Microbicides, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Dapivirine Vaginal Film is the first listed.
NCT01548560 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01548560 about?
NCT01548560 is a clinical study titled "Assessing the Safety of Dapivirine Gel and Film Formulations". This is a study to determine the safety of dapivirine gel and dapvirine film for healthy, HIV-uninfected women aged 18-45 years using the product for 7 daily doses.
What is the current status of trial NCT01548560?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 60 participants. The study started on 2012-08. Estimated completion is 2014-02.
What interventions are being tested in trial NCT01548560?
The interventions under investigation include: Dapivirine Vaginal Film (DRUG), Dapivirine Vaginal Gel (DRUG).
Who is sponsoring clinical trial NCT01548560?
This trial is sponsored by International Partnership for Microbicides, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.